Procyclidine (Kemadrin) is an anticholinergic drug that is used in the treatment of:
-
Parkinsonism, including:
-
postencephalitic,
-
arteriosclerotic, and
-
idiopathic types.
-
-
Extrapyramidal side effects induced by phenothiazines such as:
-
Dystonia,
-
Dyskinesia,
-
Akathisia, and
-
Parkinsonism.
-
Procyclidine dose in Adults
Procyclidine dose in the treatment of Parkinson disease:
- 2.5 mg orally thrice daily after meals.
- After each meal, the amount is progressively increased to 5 mg, and if necessary, 5 mg is also given at bedtime.
- The bedtime dose may be omitted in some patients who are intolerant.
Conversion from alternative therapy:
- Give a lesser dose, 2.5 mg three times per day, and gradually increase it based on the response and side effects.
Extrapyramidal side effects:
- 2.5 mg three times a day orally after meals.
- The dose is increased in increments of 2.5 mg daily (until improvement is noted) to the usual dose of 10 - 20 mg daily.
Procyclidine dose in Children
Pediatric patients have not yet been studied for safety and effectiveness.
Pregnancy Risk Category: C
- Its use in pregnancy is not well documented.
Use of procyclidine while breastfeeding
- It is unknown if the drug will be excreted into breastmilk.
Procyclidine dose in Kidney Disease:
It should be used with caution in renal impairment. However, the manufacturer has not recommended any adjustment in the dose in patients with renal disease.
Procyclidine dose in Liver Disease:
You should use caution if you have liver disease. The manufacturer has not advised any adjustments in the dose for patients with liver disease
Procyclidine side effects:
-
Central Nervous System:
- Dizziness
-
Dermatologic:
- Skin Rash
-
Gastrointestinal:
- Constipation
- Epigastric Distress
- Nausea
- Vomiting
- Xerostomia
-
Hypersensitivity:
- Hypersensitivity Reaction
-
Neuromuscular & Skeletal:
- Weakness
-
Ophthalmic:
- Blurred Vision
- Mydriasis
Contraindication to Procyclidine (Kemadrin) Include:
- Angle-closure Glaucoma
Warnings and precautions
-
Hyperthermia/ anhidrosis:
- Anhidrosis and hyperthermia are side effects of anticholinergic medications that can sometimes be severe, especially during hot weather.
- In such cases, treatment must be stopped.
- Hyperthermia is a serious condition that can affect the elderly, CNS patients, and people who have been exposed to hot environments for a long time.
-
CNS effects
- Use of procyclidine may cause confusion, restlessness and hallucinations.
- This is more evident in patients with neurological disorders or older people who are taking higher doses.
- CNS depression may also be caused by it. It should be used with caution by patients who are required to remain alert for mental tasks.
- A physician should be notified if there are any neuropsychiatric symptoms.
-
Cardiovascular disease
- Patients suffering from cardiac disease (tachycardias, arrhythmias, hypertension or hypotension) should be cautious.
-
Obstructive GI:
- Patients suffering from obstructive gastropathy should be cautious.
-
Hepatic impairment
- Patients with hepatic impairment need to be cautious.
-
Prostatic hyperplasia/Urinary stricture:
- It is possible to have urinary retention, especially among the elderly, people with BPH, or those who have had a history urinary stricture, or those with a history urinary retention.
-
Renal impairment
- It should be used with caution by patients with impaired renal function.
Procyclidine (United States: Not available): Drug Interaction
Acetylcholinesterase Inhibitors |
May diminish the therapeutic effect of Anticholinergic Agents. Anticholinergic Agents may diminish the therapeutic effect of Acetylcholinesterase Inhibitors. |
Amantadine |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Anticholinergic Agents |
May enhance the adverse/toxic effect of other Anticholinergic Agents. |
Botulinum Toxin-Containing Products |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Cannabinoid-Containing Products |
Anticholinergic Agents may enhance the tachycardic effect of Cannabinoid-Containing Products. Exceptions: Cannabidiol. |
Chloral Betaine |
May enhance the adverse/toxic effect of Anticholinergic Agents. |
Gastrointestinal Agents (Prokinetic) |
Anticholinergic Agents may diminish the therapeutic effect of Gastrointestinal Agents (Prokinetic). |
Glucagon |
Anticholinergic Agents may enhance the adverse/toxic effect of Glucagon. Specifically, the risk of gastrointestinal adverse effects may be increased. |
Itopride |
Anticholinergic Agents may diminish the therapeutic effect of Itopride. |
Mianserin |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Mirabegron |
Anticholinergic Agents may enhance the adverse/toxic effect of Mirabegron. |
Nitroglycerin |
Anticholinergic Agents may decrease the absorption of Nitroglycerin. Specifically, anticholinergic agents may decrease the dissolution of sublingual nitroglycerin tablets, possibly impairing or slowing nitroglycerin absorption. |
Opioid Agonists |
Anticholinergic Agents may enhance the adverse/toxic effect of Opioid Agonists. Specifically, the risk for constipation and urinary retention may be increased with this combination. |
Ramosetron |
Anticholinergic Agents may enhance the constipating effect of Ramosetron. |
Thiazide and Thiazide-Like Diuretics |
Anticholinergic Agents may increase the serum concentration of Thiazide and Thiazide-Like Diuretics. |
Topiramate |
Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. |
Risk Factor D (Consider therapy modification) |
|
Pramlintide |
May enhance the anticholinergic effect of Anticholinergic Agents. These effects are specific to the GI tract. |
Secretin |
|
Risk Factor X (Avoid combination) |
|
Aclidinium |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Cimetropium |
Anticholinergic Agents may enhance the anticholinergic effect of Cimetropium. |
Eluxadoline |
Anticholinergic Agents may enhance the constipating effect of Eluxadoline. |
Glycopyrrolate (Oral Inhalation) |
Anticholinergic Agents may enhance the anticholinergic effect of Glycopyrrolate (Oral Inhalation). |
Glycopyrronium (Topical) |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Ipratropium (Oral Inhalation) |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Levosulpiride |
Anticholinergic Agents may diminish the therapeutic effect of Levosulpiride. |
Oxatomide |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Potassium Chloride |
Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride. Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride. |
Potassium Citrate |
Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Citrate. |
Revefenacin |
Anticholinergic Agents may enhance the anticholinergic effect of Revefenacin. |
Tiotropium |
Anticholinergic Agents may enhance the anticholinergic effect of Tiotropium. |
Umeclidinium |
May enhance the anticholinergic effect of Anticholinergic Agents. |
Monitor:
- Extrapyramidal symptoms, Parkinson's disease.
- Pulse
- Anticholinergic effects such as CNS, bladder and bowel function
How to administer Procyclidine (Kemadrin)?
It should be taken after a meal to minimize the anticholinergic side effects and maximize the gastrointestinal tolerance.
Mechanism of action of Procyclidine (Kemadrin):
- It is an anticholinergic drug, which acts by blocking the cerebral acetylcholine receptors.
- It reduces salivation and acts on the smooth muscles to prevent spasm. It can also cause mydriasis.
The onset of action is 45 - 60 minutes.
The duration of action lasts for up to 12 hours.
Distribution: V : 1 L/kg.
Metabolism: It is metabolized by hydroxylation of the alicyclic groups.
Bioavailability is about 75%
Half-life elimination: about 12.6 hours
Time to reach peak plasma concentration is about 1.1 hours
Excretion: is via Urine (predominantly as metabolites)
International Brands of Procyclidine:
- PDP-Procyclidine
- Akinetic
- Cyclid
- Emadrin
- Kemadrin
- Osnervan
- Picidin
- Proimer
- Youngproma
Procyclidine Brands in Pakistan:
Procyclidine (Hcl) [Inj 10 M/2ml] |
|
Zyclidine | Mass Pharma (Private) Limited |
Procyclidine (Hcl) [Inj 10 Mg/2ml] |
|
Epsent | Genetics Pharmaceuticals |
Xprodine | Mass Pharma (Private) Limited |
Procyclidine (Hcl) [Tabs 5 Mg] |
|
Cyclidine | Pharmedic (Pvt) Ltd. |
Kemadrin | Glaxosmithkline |
Kempro | Adamjee Pharmaceuticals (Pvt) Ltd. |
Procholidin | Zafa Pharmaceutical Laboratories (Pvt) Ltd. |
Procye | Glitz Pharma |
Prosyclidine | Werrick Pharmaceuticals |
Procyclidine (Hcl) [Tabs 50 Mg] |
|
Zyclofenac-P | Zephyr Pharmatec (Pvt) Ltd. |